cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Poseida Therapeutics Inc
4 own
2 watching
Current Price
$2.03
$-0.4
(-16.46%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
201.26M
52-Week High
52-Week High
4.27000
52-Week Low
52-Week Low
1.54000
Average Volume
Average Volume
1.44M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization201.26M
icon52-Week High4.27000
icon52-Week Low1.54000
iconAverage Volume1.44M
iconDividend Yield--
iconP/E Ratio--
What does the Poseida Therapeutics Inc do?
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.
Read More
How much money does Poseida Therapeutics Inc make?
News & Events about Poseida Therapeutics Inc.
PR Newswire
9 months ago
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-CD19CD20-ALLO1, an Allogeneic Dual CAR-T Cell Therapy for B-Cell Malignancies Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-CD19CD20-ALLO1, an Allogeneic Dual...
PR Newswire
9 months ago
Poseida Therapeutics to Join Russell 3000 and Russell 2000 Indexes Poseida Therapeutics to Join Russell 3000 and Russell 2000 Indexes PR Newswire SAN DIEGO, June 26, 2023 SAN DIEGO, June 26, 2023 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy...
PR Newswire
1 year ago
Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy for Hemophilia A at the 64th ASH Annual Meeting & Exposition Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy for Hemophilia A at the 64th ASH Annual Meeting & Exposition PR...
Ticker Report
1 year ago
Poseida Therapeutics, Inc. (NASDAQ:PSTX Get Rating) Analysts at William Blair decreased their FY2023 EPS estimates for Poseida Therapeutics in a research note issued on Thursday, November 10th. William Blair analyst R. Prasad now expects that the company will post earnings of $0.89 ...
Frequently Asked Questions
Frequently Asked Questions
What is Poseida Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Poseida Therapeutics Inc shares?
plus_minus_icon
How can I buy Poseida Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Poseida Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Poseida Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Poseida Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Poseida Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Poseida Therapeutics Inc?
plus_minus_icon
What percentage is Poseida Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Poseida Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.03
$-0.4
(-16.46%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00